Crispr Therapeutics Ag (CRSP) Directors and Executive Officers

Officers & Directors

Samarth Kulkarni
Chief Executive Officer, Chairman and Director

Ali Behbahani
Director

John Greene
Director

Douglas Treco
Director

Maria Fardis
Director

Simeon J. George
Director

Raju Prasad
Chief Financial Officer, Authorized Representative in the United States

Katherine High
Director

H. Edward Fleming, Jr.
Director ,

Crispr Therapeutics Ag currently has 201 employees.

News about Crispr Therapeutics Ag Key Personnel

CRISPR Therapeutics: A Gene Editing Pioneer Struggles Amidst Milestones

Overview of Recent DevelopmentsCRISPR Therapeutics, a trailblazer in the realm of gene editing technologies, has recently made noteworthy progress in the treatment of severe genetic disorders, specifically sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). The recent approval of its innovative therapy, CASGEVY (exagamglogene autotemcel), alongside the presentation of promising preliminary data for its drug CTX112 at the 2024 American Society of Hematology (ASH) Annual Meeting, underscores the company’s commitment to transforming patient care through groundbreaking therapies. However, despite these scientific advancements, CRISPR Therapeutics faces a dual challenge: operational effi...